Plasma Brain-Derived Tau in Prognosis of Large Vessel Occlusion Ischemic Stroke
- 1 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (9) , 2353-2358
Abstract
BACKGROUND: Large vessel occlusion acute ischemic stroke prognosis improved following the 2015 endovascular therapy (EVT) trials. Blood-based biomarkers may improve outcome prediction. We aimed to assess plasma brain-derived tau (BD-Tau) performance in predicting post-EVT large vessel occlusion acute ischemic stroke outcomes. METHODS: We included 2 temporally independent prospective cohorts of anterior circulation in patients with large vessel occlusion acute ischemic stroke who successfully recanalized post-EVT. We measured plasma BD-Tau, GFAP (glial-fibrillary-acidic-protein), NfL (neurofilament-light-chain), and total-Tau upon admission, immediately, 24 hours, and 72 hours post-EVT. Twenty-four-hour neuroimaging and 90-day functional outcomes were independently assessed using the Alberta Stroke Program Early Computed Tomography Score (good outcome: >7 or unchanged) and the modified Rankin Scale (favorable outcome P P P <0.001). CONCLUSIONS: Admission plasma BD-Tau accurately predicted 90-day functional outcomes in patients with large vessel occlusion acute ischemic stroke after successful EVT. The proposed model may predict functional outcomes using objective measures, minimizing human-related biases and serving as a simplified prognostic tool for AIS.Keywords
This publication has 10 references indexed in Scilit:
- Mechanical thrombectomy decision making and prognostication: Stroke treatment Assessments prior to Thrombectomy In Neurointervention (SATIN) studyJournal of NeuroInterventional Surgery, 2023
- Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegenerationBrain, 2022
- Special issue on blood biomarkers in neurologyActa Neurologica Scandinavica, 2022
- Outcome Prediction Models for Endovascular Treatment of Ischemic Stroke: Systematic Review and External ValidationStroke, 2022
- Early plasma biomarker dynamic profiles are associated with acute ischemic stroke outcomesEuropean Journal of Neurology, 2022
- Prediction of Outcome After Endovascular Embolectomy in Anterior Circulation Stroke Using BiomarkersTranslational Stroke Research, 2021
- Functional Outcome Following Stroke Thrombectomy in Clinical PracticeStroke, 2019
- Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic strokeBMC Neurology, 2017
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Cerebrospinal Fluid Tau Levels Increase with Age in Healthy IndividualsDementia and Geriatric Cognitive Disorders, 2001